ARCHIVES

Imbruvica Improves PFS, OS In Phase III CLL Study

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Senate Subcommittee Gives NCI 41.397 Billion for FY ‘87

August 8, 1986

High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer

November 27, 2009

Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial

November 10, 1989

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

In Brief: NCAB Objects To Low Priority For Several Cancer Control Grants, Asks For New Review

June 22, 1979

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003